Peripheral opioid receptors mediating antinociception in inflammation. Activation by endogenous opioids and role of the pituitary-adrenal axis
- 1 April 1990
- journal article
- research article
- Published by Wolters Kluwer Health in Pain
- Vol. 41 (1) , 81-93
- https://doi.org/10.1016/0304-3959(90)91112-v
Abstract
This study investigated the involvement of endogenous opioid peptides in mediating cold water swim (CWS) stress-induced antinociception (SIA) in rats with unilateral hind paw inflammation induced by Freund's complete adjuvant (FCA). Following 0.5, 1 and 2 min of CWS, there was a duration-dependent elevation of paw pressure threshold (PPT) in both inflamed and non-inflamed paws which was maximal immediately after CWS and returned to control values within 15 min. The antinociception elicited in the inflamed paw was significantly greater than that elicited in the non-inflamed paw. The antinociception induced by a 1 min CWS was dose dependently antagonized by tertiary naloxone (0.125–1 mg/kg s.c.) and completely reversed by tertiary naltrexone (0.5 mg/kg). Quaternary naltrexone (5–40 mg/kg s.c.) was similarly effective in reversing the elevation of inflamed PPT induced by a 1 min CWS stress. In contrast, similar doses of quaternary naltrexone had no effect against centrally mediated morphine antinociception in non-inoculated rats. Adrenalectomy was without effect on the pattern of SIA seen in FCA-treated rats. Surgical hypophysectomy completely abolished the differential antinociception induced by 0.5 and l min durations of CWS but had little effect on that following 2 min of CWS stress. Inhibition of hypophysial corticotrophic cell secretion with dexamethasone (300 μg/kg) injected s.c. 120 min prior to CWS completely abolished the differential SIA at all durations of CWS tested. β-Endorphin 12.5 μg/kg administered i.v. in non-stressed rats also caused a greater elevation of PPT in inflamed than in non-inflamed paws. This effect was not reversed by concomitant i.v. administration of (−) tertiary naloxone 5 mg/kg or quaternary naltrexone 20 mg/kg.This publication has 53 references indexed in Scilit:
- Prodynorphin gene expression is enhanced in the spinal cord of chronic arthritic ratsNeuroscience Letters, 1987
- The use of quaternary narcotic antagonists in opiate researchNeuropharmacology, 1985
- Is methylnalorphinium the prototype of an ideal peripheral analgesic?European Journal of Pharmacology, 1984
- Dynorphin-related immunoreactive peptides in rat brain and pituitaryNeuroscience Letters, 1980
- II - Prostaglandin hyperalgesia: The peripheral analgesic activity of morphine, enkephalins and opioid antagonistsProstaglandins, 1979
- The pituitary gland mediates acute and chronic pain responsiveness in stressed and non-stressed ratsLife Sciences, 1979
- Distribution of methionine- and leucine-enkephalin within the rat pituitary gland measured by highly specific radioimmunoassaysBiochemical and Biophysical Research Communications, 1978
- Radioimmunoassay of β-endorphin basal and stimulated levels in extracted rat plasmaNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1978
- Dose-dependent reductions by naloxone of analgesia induced by cold-water stressPharmacology Biochemistry and Behavior, 1978
- β-Endorphin and Adrenocorticotropin Are Selected Concomitantly by the Pituitary GlandScience, 1977